研究单位:[1]Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology[2]Swedish Orphan Biovitrum[3]Swedish Orphan Biovitrum Research Site,Beijing,China[4]Swedish Orphan Biovitrum Research Site,Chongqing,China[5]Swedish Orphan Biovitrum Research Site,Hefei,China[6]Swedish Orphan Biovitrum Research Site,Wuhan,China
This is a prospective, non-interventional, non-comparative, multicenter study to collect data on HT-1 patients in China treated with Nitisinone in a routine clinical setting. No tests or examinations are mandated in the study.